Torrent Pharmaceuticals Ltd
₹4738.50
+88.50 (1.90%)
Fri, 06 Nov 2026, 09:41 pm
Health Technology
Pharmaceuticals: Major
24.5KTorrent Pharmaceuticals Share Price Live Chart
1 Day
+88.50 (1.90%)
No Result Found
Summary
Market Cap (in Cr)
179455.65
Net Profit (in Cr)
2138.18
P/B
17.03
Sector P/E
38.43
P/E
66.03
EV/EBITDA
35.81
Debt/Equity (Industry)
0.33
Interest Cover (Industry)
13.04
ROCE (Industry)
14.50
RONW (Industry)
13.64
ROE
26.76
ROCE
18.30
Debt/Equity
1.14
EPS (TTM)
57.08
Dividend Yield
0.72
Book Value
483.04
Interest Cover
8.46
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (3.6x coverage).
- Dividends after 3 years are expected to be well covered by earnings (3x coverage).
- Cash flow for Torrent Pharmaceuticals is expected to increase by more than 50% in 2 years time.
- Torrent Pharmaceuticals's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Torrent Pharmaceuticals's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Torrent Pharmaceuticals's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Torrent Pharmaceuticals's earnings are expected to grow by 16.6% yearly, however this is not considered high growth (20% yearly).
- Torrent Pharmaceuticals's earnings growth is positive but not above the India market average.
Shareholding
| Shareholders | SEPT 2026 | JUN 2026 | MAR 2026 | DEC 2025 | SEPT 2025 |
|---|---|---|---|---|---|
| Promoters | 60.78 | 68.31 | 68.31 | 68.31 | 68.31 |
| FII | 17.22 | 15.44 | 16.18 | 16.13 | 15.92 |
| DII | 13.46 | 9.83 | 9.06 | 9.14 | 9.28 |
| Public | 8.54 | 6.42 | 6.45 | 6.42 | 6.49 |
| Government | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 5317.63 | 4973.93 | 4793.67 | 4630.23 | 4449.97 | 4286.53 | 3942.83 |
| Fibonacci | 4973.93 | 4842.64 | 4761.53 | 4630.23 | 4498.94 | 4417.83 | 4286.53 |
| Camarilla | 4707.92 | 4676.41 | 4644.91 | 4630.23 | 4581.89 | 4550.39 | 4518.88 |
Pivots Level: Classic
R3
+687.40
5317.63
R2
+343.70
4973.93
R1
+163.43
4793.67
S1
-180.27
4449.97
S2
-343.70
4286.53
S3
-687.40
3942.83
Moving Average
Period
Value
10-EMA
4662.94
20-EMA
4663.14
30-EMA
4689.20
50-EMA
4728.14
100-EMA
4706.11
200-EMA
4511.28
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 23 Oct 2026 | board-meetings | Accounts, Quarterly Results | |
| 01 Jun 2026 | agm | ||
| 22 May 2026 | dividend | ₹9.00 Dividend /Share | 29 May 2026 |
| 22 May 2026 | board-meetings | Accounts, Final Dividend, Raising funds through Debt Instr. | |
| 27 Mar 2026 | egm | ||
| 13 Feb 2026 | board-meetings | Quarterly Results, Interim Dividend | |
| 13 Feb 2026 | dividend | ₹29.00 Dividend /Share | 19 Feb 2026 |
| 18 Jan 2026 | dividend | Interim Dividend - Rs 29 Per Share | 19 Feb 2026 |
| 07 Nov 2025 | board-meetings | Quarterly Results | |
| 04 Jul 2025 | agm |
Peer Comparison
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Dr Reddys Laboratories Ltd
Zydus Lifesciences Ltd
Divis Laboratories Ltd
Laurus Labs Ltd
Torrent Pharmaceuticals Ltd About
Torrent Pharmaceuticals is engaged in manufacturing, developing and marketing of generic pharmaceutical formulations.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1972
Headquarters
CEO
Sudhir Mehta
Employees
Contact
Website
http://www.torrentpharma.com
investorservices@torrentpharma.com
Phone
91-79-26599000
Location
Torrent House, Off Ashram Road, Ahmedabad, Gujarat, 380009
Torrent Pharmaceuticals Ltd Company History
| Year | History |
|---|---|
| 2019 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| UBS PRINCIPAL CAPITAL ASIA LIMITED | block | Sell | 44810 | 3252.1 | 23 Jan 2025 |
| UBS AG | block | Buy | 44810 | 3252.1 | 23 Jan 2025 |
| TORRENT INVESTMENTS PRIVATE LIMITED | bulk | Sell | 4972020 | 3103.07 | 30 Oct 2024 |
| TORRENT INVESTMENTS PRIVATE LIMITED | bulk | Sell | 4972020 | 3104.4 | 30 Oct 2024 |
| SEB ASIENFOND EX JAPAN | block | Buy | 63294 | 2691.2 | 07 Mar 2024 |
| SEB FUND 3 SEB PENSION FUND | block | Sell | 63294 | 2691.2 | 07 Mar 2024 |
| BNP PARIBAS ARBITRAGE | block | Sell | 55561 | 2507.05 | 25 Jan 2024 |
| SOCIETE GENERALE | block | Buy | 474629 | 2507.05 | 25 Jan 2024 |
| MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND | block | Buy | 47322 | 2507.05 | 25 Jan 2024 |
| MARSHALL WACE INVESTMENT STRATEGIESGTOPS FUND | block | Buy | 4356 | 2507.05 | 25 Jan 2024 |
Frequently Asked Questions
1.What is the stock price of Torrent Pharmaceuticals Ltd?
As of 07/11/2026 at 3:11 AM, Torrent Pharmaceuticals Ltd shares are trading at ₹4738.50.
2.What is the market cap. of Torrent Pharmaceuticals Ltd?
As of 07/11/2026, the market capitalization of Torrent Pharmaceuticals Ltd is ₹1,76,294.19 crore.
3.When was Torrent Pharmaceuticals Ltd founded?
Torrent Pharmaceuticals Ltd was founded in 1972.
4.What are the P/E and P/B ratios of Torrent Pharmaceuticals Ltd?
As of 07/11/2026, Torrent Pharmaceuticals Ltd has a P/E ratio of 77.64 and a P/B ratio of 17.03.
5.How can I buy shares of Torrent Pharmaceuticals Ltd?
You can buy shares of Torrent Pharmaceuticals Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Torrent Pharmaceuticals Ltd?
As of September,2026, promoters hold 60.78% in Torrent Pharmaceuticals Ltd, while FIIs, DIIs and public shareholders hold 17.22%, 13.46% and 8.54%, respectively. The government holds 0.00%.
7.Does Torrent Pharmaceuticals Ltd pay dividends?
Yes, Torrent Pharmaceuticals Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹₹9.00 Dividend /Share per share.
8.What is the dividend yield of Torrent Pharmaceuticals Ltd?
As of 07 November, 2026, the dividend yield of Torrent Pharmaceuticals Ltd stands at 0.82%.
9.What are the latest financial results of Torrent Pharmaceuticals Ltd?
For the financial year ended March 2025, Torrent Pharmaceuticals Ltd reported revenue of ₹11,358.00 crore and a net profit of ₹1,911.00 crore.
10.What is the Stock symbol of Torrent Pharmaceuticals Ltd?
TORNTPHARM is the stock symbol of Torrent Pharmaceuticals Ltd.
11.Who is the CEO of Torrent Pharmaceuticals Ltd?
The CEO of Torrent Pharmaceuticals Ltd is Sudhir Mehta.
